Marvell (MRVL) PT Lowered to $13 at BofA/Merrill Lynch on Weak Qtr
BofA/Merrill Lynch analyst Vivek Arya reiterated an Underperform rating and lowered its price target on Marvell (NASDAQ: MRVL) to $13.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
